EDIT
HealthcareEditas Medicine, Inc.
$2.44-0.10 (-4.13%)
Prev Close
$2.54
Open
$2.60
High
$2.64
Low
$2.42
Volume
951.3K
Market Cap
$227.0M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Editas Medicine, Inc. (EDIT) has been exclusively selling, with 0 insider purchases totaling $0.00 and 14 insider sales totaling $101.6K. The most recent insider transaction was by Burkly Linda (officer: EVP, CHIEF SCIENTIFIC OFFICER), who sold $3.0K worth of shares on Mar 4, 2026. Editas Medicine, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $227.0M.
Buys (12M)
0
$0.00
Sells (12M)
14
$101.6K
Net Activity
Net Seller
$101.6K
Active Insiders
3
last 12 mo
EDIT Price Chart
EDIT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026↗ | Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | Sell | 1,498 | $2.02 | $3.0K | 68,028 |
| Mar 4, 2026↗ | O'Neill Gilmore Neil | director, officer: CEO | Sell | 10,788 | $2.02 | $21.8K | 263,693 |
| Mar 4, 2026↗ | Parison Amy | officer: SVP, Chief Financial Officer | Sell | 948 | $2.02 | $1.9K | 15,434 |
| Dec 3, 2025↗ | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 713 | $2.15 | $1.5K | 0 |
| Dec 3, 2025↗ | O'Neill Gilmore Neil | CEO | Sell | 5,603 | $2.15 | $12.1K | 0 |
| Dec 3, 2025↗ | Parison Amy | SVP, Chief Financial Officer | Sell | 461 | $2.15 | $992.58 | 0 |
| Sep 3, 2025↗ | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 710 | $2.60 | $1.8K | 0 |
| Sep 3, 2025↗ | O'Neill Gilmore Neil | CEO | Sell | 5,592 | $2.60 | $14.5K | 0 |
| Sep 3, 2025↗ | Parison Amy | SVP, Chief Financial Officer | Sell | 458 | $2.60 | $1.2K | 0 |
| Aug 7, 2025↗ | Parison Amy | SVP, Chief Financial Officer | Sell | 679 | $2.58 | $1.8K | 0 |
| Jul 31, 2025↗ | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 5,121 | $2.49 | $12.8K | 0 |
| Jun 3, 2025↗ | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 726 | $1.72 | $1.3K | 0 |
| Jun 3, 2025↗ | O'Neill Gilmore Neil | CEO | Sell | 15,192 | $1.72 | $26.2K | 0 |
| Jun 3, 2025↗ | Parison Amy | SVP, Chief Financial Officer | Sell | 446 | $1.72 | $768.90 | 0 |
| Mar 4, 2025↗ | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 2,891 | $1.71 | $4.9K | 0 |
| Mar 4, 2025↗ | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | Sell | 4,109 | $1.71 | $7.0K | 0 |
| Mar 4, 2025↗ | O'Neill Gilmore Neil | CEO | Sell | 16,632 | $1.71 | $28.5K | 0 |
| Dec 3, 2024↗ | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Sell | 541 | $2.08 | $1.1K | 0 |
| Dec 3, 2024↗ | O'Neill Gilmore Neil | CEO | Sell | 1,618 | $2.08 | $3.4K | 0 |
| Sep 4, 2024↗ | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Sell | 518 | $3.42 | $1.8K | 0 |
| Sep 4, 2024↗ | O'Neill Gilmore Neil | CEO | Sell | 1,555 | $3.42 | $5.3K | 0 |
| Jul 25, 2024↗ | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 11,886 | $5.42 | $64.4K | 0 |
| Jul 19, 2024↗ | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Sell | 6,619 | $5.21 | $34.5K | 0 |
| Jun 4, 2024↗ | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Sell | 511 | $5.50 | $2.8K | 0 |
| Jun 4, 2024↗ | O'Neill Gilmore Neil | CEO | Sell | 12,191 | $5.50 | $67.0K | 0 |
| May 20, 2024↗ | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | Sell | 22,337 | $5.61 | $125.4K | 0 |
| May 13, 2024↗ | Hopfield Jessica | Director | Buy | 45,000 | $5.64 | $253.9K | 0 |
| Mar 2, 2024↗ | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | Sell | 20,327 | $9.42 | $191.4K | 0 |
| Mar 2, 2024↗ | O'Neill Gilmore Neil | CEO | Sell | 77,824 | $9.42 | $732.9K | 0 |
| Dec 5, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 103 | $10.90 | $1.1K | 0 |
| Nov 14, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 695 | $8.21 | $5.7K | 0 |
| Nov 7, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 139 | $8.40 | $1.2K | 0 |
| Sep 6, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 103 | $8.82 | $908.46 | 0 |
| Aug 11, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 702 | $8.59 | $6.0K | 0 |
| Aug 8, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 141 | $8.39 | $1.2K | 0 |
| Jul 19, 2023↗ | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | Sell | 4,317 | $8.80 | $38.0K | 0 |
| Jun 5, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 105 | $9.50 | $997.82 | 0 |
| Jun 5, 2023↗ | O'Neill Gilmore Neil | CEO | Sell | 6,486 | $9.50 | $61.6K | 0 |
| May 11, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 668 | $9.87 | $6.6K | 0 |
| May 11, 2023↗ | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | 949 | $9.87 | $9.4K | 0 |
| May 9, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 135 | $9.51 | $1.3K | 0 |
| Mar 2, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 101 | $8.89 | $897.89 | 0 |
| Mar 2, 2023↗ | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | 184 | $8.89 | $1.6K | 0 |
| Feb 13, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 3,307 | $9.67 | $32.0K | 0 |
| Feb 13, 2023↗ | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | 4,287 | $9.67 | $41.4K | 0 |
| Feb 13, 2023↗ | Shearman Mark S | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 2,790 | $9.67 | $27.0K | 0 |
| Feb 7, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 346 | $11.10 | $3.8K | 0 |
| Jan 10, 2023↗ | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | 1,752 | $8.16 | $14.3K | 0 |
| Dec 5, 2022↗ | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sell | 102 | $10.23 | $1.0K | 0 |
| Dec 5, 2022↗ | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | 193 | $10.23 | $2.0K | 0 |
| Nov 8, 2022↗ | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sell | 289 | $11.02 | $3.2K | 0 |
| Sep 6, 2022↗ | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sell | 101 | $15.01 | $1.5K | 0 |
| Sep 6, 2022↗ | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | 192 | $15.01 | $2.9K | 0 |
| Aug 9, 2022↗ | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sell | 293 | $18.60 | $5.4K | 0 |
| Jun 15, 2022↗ | Shearman Mark S | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 5,145 | $10.06 | $51.7K | 0 |
| Jun 3, 2022↗ | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sell | 1,123 | $11.54 | $13.0K | 0 |
| Jun 3, 2022↗ | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | 1,527 | $11.54 | $17.6K | 0 |
| May 9, 2022↗ | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sell | 297 | $13.11 | $3.9K | 0 |
| Mar 3, 2022↗ | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sell | 403 | $17.33 | $7.0K | 0 |
| Mar 3, 2022↗ | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | 767 | $17.33 | $13.3K | 0 |
| Feb 8, 2022↗ | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sell | 302 | $17.63 | $5.3K | 0 |
| Jan 11, 2022↗ | ROBERTSON MICHELLE | Chief Financial Officer | Sell | 1,744 | $25.70 | $44.8K | 0 |
| Jan 3, 2022↗ | MULLEN JAMES C | CEO | Sell | 18,252 | $26.95 | $492.0K | 0 |
| Nov 12, 2021↗ | Michaels Lisa Anne | EVP/Chief Medical Officer | Sell | 1,568 | $38.33 | $60.1K | 0 |
| Nov 9, 2021↗ | Eaton Bruce | EVP, Chief Business Officer | Sell | 287 | $40.61 | $11.7K | 0 |
| Oct 18, 2021↗ | MULLEN JAMES C | CEO | Sell | 13,805 | $38.03 | $525.0K | 0 |
| Aug 9, 2021↗ | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sell | 1,545 | $26.61 | $41.1K | 0 |
| Aug 9, 2021↗ | ROBERTSON MICHELLE | Chief Financial Officer | Sell | 2,500 | $60.00 | $150.0K | 0 |
| Jun 28, 2021↗ | ROBERTSON MICHELLE | Chief Financial Officer | Sell | 2,500 | $50.00 | $125.0K | 0 |
| Mar 3, 2021↗ | Hopfield Jessica | Director | Buy | 5,800 | $45.51 | $264.0K | 0 |
| Mar 2, 2021↗ | MULLEN JAMES C | CEO | Buy | 25,000 | $46.27 | $1.16M | 0 |
EDIT Insider Buying Activity
The following table shows recent insider purchases of Editas Medicine, Inc. (EDIT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 13, 2024↗ | Hopfield Jessica | Director | Buy | 45,000 | $5.64 | $253.9K | 0 |
| Mar 3, 2021↗ | Hopfield Jessica | Director | Buy | 5,800 | $45.51 | $264.0K | 0 |
| Mar 2, 2021↗ | MULLEN JAMES C | CEO | Buy | 25,000 | $46.27 | $1.16M | 0 |
EDIT Insider Selling Activity
The following table shows recent insider sales of Editas Medicine, Inc. (EDIT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026↗ | Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | Sell | 1,498 | $2.02 | $3.0K | 68,028 |
| Mar 4, 2026↗ | O'Neill Gilmore Neil | director, officer: CEO | Sell | 10,788 | $2.02 | $21.8K | 263,693 |
| Mar 4, 2026↗ | Parison Amy | officer: SVP, Chief Financial Officer | Sell | 948 | $2.02 | $1.9K | 15,434 |
| Dec 3, 2025↗ | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 713 | $2.15 | $1.5K | 0 |
| Dec 3, 2025↗ | O'Neill Gilmore Neil | CEO | Sell | 5,603 | $2.15 | $12.1K | 0 |
| Dec 3, 2025↗ | Parison Amy | SVP, Chief Financial Officer | Sell | 461 | $2.15 | $992.58 | 0 |
| Sep 3, 2025↗ | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 710 | $2.60 | $1.8K | 0 |
| Sep 3, 2025↗ | O'Neill Gilmore Neil | CEO | Sell | 5,592 | $2.60 | $14.5K | 0 |
| Sep 3, 2025↗ | Parison Amy | SVP, Chief Financial Officer | Sell | 458 | $2.60 | $1.2K | 0 |
| Aug 7, 2025↗ | Parison Amy | SVP, Chief Financial Officer | Sell | 679 | $2.58 | $1.8K | 0 |
| Jul 31, 2025↗ | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 5,121 | $2.49 | $12.8K | 0 |
| Jun 3, 2025↗ | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 726 | $1.72 | $1.3K | 0 |
| Jun 3, 2025↗ | O'Neill Gilmore Neil | CEO | Sell | 15,192 | $1.72 | $26.2K | 0 |
| Jun 3, 2025↗ | Parison Amy | SVP, Chief Financial Officer | Sell | 446 | $1.72 | $768.90 | 0 |
| Mar 4, 2025↗ | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 2,891 | $1.71 | $4.9K | 0 |
| Mar 4, 2025↗ | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | Sell | 4,109 | $1.71 | $7.0K | 0 |
| Mar 4, 2025↗ | O'Neill Gilmore Neil | CEO | Sell | 16,632 | $1.71 | $28.5K | 0 |
| Dec 3, 2024↗ | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Sell | 541 | $2.08 | $1.1K | 0 |
| Dec 3, 2024↗ | O'Neill Gilmore Neil | CEO | Sell | 1,618 | $2.08 | $3.4K | 0 |
| Sep 4, 2024↗ | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Sell | 518 | $3.42 | $1.8K | 0 |
| Sep 4, 2024↗ | O'Neill Gilmore Neil | CEO | Sell | 1,555 | $3.42 | $5.3K | 0 |
| Jul 25, 2024↗ | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 11,886 | $5.42 | $64.4K | 0 |
| Jul 19, 2024↗ | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Sell | 6,619 | $5.21 | $34.5K | 0 |
| Jun 4, 2024↗ | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Sell | 511 | $5.50 | $2.8K | 0 |
| Jun 4, 2024↗ | O'Neill Gilmore Neil | CEO | Sell | 12,191 | $5.50 | $67.0K | 0 |
| May 20, 2024↗ | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | Sell | 22,337 | $5.61 | $125.4K | 0 |
| Mar 2, 2024↗ | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | Sell | 20,327 | $9.42 | $191.4K | 0 |
| Mar 2, 2024↗ | O'Neill Gilmore Neil | CEO | Sell | 77,824 | $9.42 | $732.9K | 0 |
| Dec 5, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 103 | $10.90 | $1.1K | 0 |
| Nov 14, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 695 | $8.21 | $5.7K | 0 |
| Nov 7, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 139 | $8.40 | $1.2K | 0 |
| Sep 6, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 103 | $8.82 | $908.46 | 0 |
| Aug 11, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 702 | $8.59 | $6.0K | 0 |
| Aug 8, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 141 | $8.39 | $1.2K | 0 |
| Jul 19, 2023↗ | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | Sell | 4,317 | $8.80 | $38.0K | 0 |
| Jun 5, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 105 | $9.50 | $997.82 | 0 |
| Jun 5, 2023↗ | O'Neill Gilmore Neil | CEO | Sell | 6,486 | $9.50 | $61.6K | 0 |
| May 11, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 668 | $9.87 | $6.6K | 0 |
| May 11, 2023↗ | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | 949 | $9.87 | $9.4K | 0 |
| May 9, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 135 | $9.51 | $1.3K | 0 |
| Mar 2, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 101 | $8.89 | $897.89 | 0 |
| Mar 2, 2023↗ | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | 184 | $8.89 | $1.6K | 0 |
| Feb 13, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 3,307 | $9.67 | $32.0K | 0 |
| Feb 13, 2023↗ | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | 4,287 | $9.67 | $41.4K | 0 |
| Feb 13, 2023↗ | Shearman Mark S | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 2,790 | $9.67 | $27.0K | 0 |
| Feb 7, 2023↗ | Eaton Bruce | EVP, CBO AND CTO | Sell | 346 | $11.10 | $3.8K | 0 |
| Jan 10, 2023↗ | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | 1,752 | $8.16 | $14.3K | 0 |
| Dec 5, 2022↗ | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sell | 102 | $10.23 | $1.0K | 0 |
| Dec 5, 2022↗ | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | 193 | $10.23 | $2.0K | 0 |
| Nov 8, 2022↗ | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sell | 289 | $11.02 | $3.2K | 0 |
| Sep 6, 2022↗ | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sell | 101 | $15.01 | $1.5K | 0 |
| Sep 6, 2022↗ | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | 192 | $15.01 | $2.9K | 0 |
| Aug 9, 2022↗ | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sell | 293 | $18.60 | $5.4K | 0 |
| Jun 15, 2022↗ | Shearman Mark S | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 5,145 | $10.06 | $51.7K | 0 |
| Jun 3, 2022↗ | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sell | 1,123 | $11.54 | $13.0K | 0 |
| Jun 3, 2022↗ | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | 1,527 | $11.54 | $17.6K | 0 |
| May 9, 2022↗ | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sell | 297 | $13.11 | $3.9K | 0 |
| Mar 3, 2022↗ | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sell | 403 | $17.33 | $7.0K | 0 |
| Mar 3, 2022↗ | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | 767 | $17.33 | $13.3K | 0 |
| Feb 8, 2022↗ | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sell | 302 | $17.63 | $5.3K | 0 |
| Jan 11, 2022↗ | ROBERTSON MICHELLE | Chief Financial Officer | Sell | 1,744 | $25.70 | $44.8K | 0 |
| Jan 3, 2022↗ | MULLEN JAMES C | CEO | Sell | 18,252 | $26.95 | $492.0K | 0 |
| Nov 12, 2021↗ | Michaels Lisa Anne | EVP/Chief Medical Officer | Sell | 1,568 | $38.33 | $60.1K | 0 |
| Nov 9, 2021↗ | Eaton Bruce | EVP, Chief Business Officer | Sell | 287 | $40.61 | $11.7K | 0 |
| Oct 18, 2021↗ | MULLEN JAMES C | CEO | Sell | 13,805 | $38.03 | $525.0K | 0 |
| Aug 9, 2021↗ | Eaton Bruce | EVP, CHIEF BUSINESS OFFICER | Sell | 1,545 | $26.61 | $41.1K | 0 |
| Aug 9, 2021↗ | ROBERTSON MICHELLE | Chief Financial Officer | Sell | 2,500 | $60.00 | $150.0K | 0 |
| Jun 28, 2021↗ | ROBERTSON MICHELLE | Chief Financial Officer | Sell | 2,500 | $50.00 | $125.0K | 0 |
EDIT Insiders
Similar Stocks to EDIT
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B